loading

Finanzdaten der Eliem Therapeutics Inc-Aktie (ELYM)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
41.33%
3.005
5.122 5.001 6.714 23.44
Operating Income/Loss
41.33%
-3.005
-5.122 -5.001 -6.714 -23.44
Income/Loss From Continuing Operations Before Tax
53.39%
-1.697
-3.641 -3.968 -5.22 -22.29
Income/Loss From Continuing Operations After Tax
53.39%
-1.697
-3.641 -3.968 -5.22 -22.29
Net Income/Loss
53.39%
-1.697
-3.641 -3.968 -5.22 -22.29
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
14,949%
27.64
0.1837 27.07 26.84 26.49
Diluted Average Shares
14,949%
27.64
0.1837 27.07 26.84 26.49
Basic Earnings Per Share
53.85%
-0.06
-0.13 -0.15 -0.19 -0.84
Diluted Earnings Per Share
53.85%
-0.06
-0.13 -0.15 -0.19 -0.84
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$32.27
price up icon 1.73%
$19.31
price down icon 5.82%
$4.3899
price down icon 7.43%
$353.81
price up icon 2.62%
biotechnology ONC
$221.87
price up icon 1.07%
$114.16
price down icon 1.09%
Kapitalisierung:     |  Volumen (24h):